BioLineRx (BLRX) Receivables - Net (2023 - 2025)

BioLineRx (BLRX) recorded quarterly Receivables - Net of $46000.0 in Q4 2025, down 41.03% quarter-over-quarter from $78000.0 in Q2 2025, and down 98.14% on a YoY basis from $2.5 million in Q4 2024.

BioLineRx (BLRX) Receivables - Net (2023 - 2025) Analysis & Trends

BioLineRx's Receivables - Net history runs 3 years deep, the most recent figure standing at $46000.0 for Q4 2025.

  • In Q4 2025, Receivables - Net fell 98.14% year-over-year to $46000.0; the TTM figure through Dec 2025 stood at $46000.0 (down 98.14% YoY), while the FY2025 annual figure was $46000.0, down 98.14% from the prior year.
  • Receivables - Net was $46000.0 for Q4 2025 at BioLineRx, down from $78000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $3.6 million in Q3 2024 to a low of $46000.0 in Q4 2025.
  • Historically, Receivables - Net has averaged $1.8 million across 3 years, with a median of $2.0 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Net surged 591.62% in 2024, then slumped 98.14% in 2025.
  • A 3-year view of Receivables - Net shows it stood at $358000.0 in 2023, then soared by 591.62% to $2.5 million in 2024, then plunged by 98.14% to $46000.0 in 2025.
  • The last three Receivables - Net figures came in at $46000.0 (Q4 2025), $78000.0 (Q2 2025), and $1.5 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 BioLineRx 227.63 Mn 211.90 Mn 154,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 46,000.00
Dec 31, 2025 46,000.00
Jun 30, 2025 78,000.00
Jun 30, 2025 78,000.00
Mar 31, 2025 1.47 Mn
Mar 31, 2025 1.47 Mn
Dec 31, 2024 2.48 Mn
Dec 31, 2024 2.48 Mn
Sep 30, 2024 3.61 Mn
Sep 30, 2024 3.61 Mn
Jun 30, 2024 3.18 Mn
Jun 30, 2024 3.18 Mn
Mar 31, 2024 2.83 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 358,000.00
Dec 31, 2023 358,000.00